Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Tetrahedron|December 15, 2010
Synthesis of (2R, 3R)-epigallocatechin-3-O-(4-hydroxybenzoate), a novel catechin from Cistus salvifolius, and evaluation of its proteasome inhibitory activitiesKumi Osanai, Congde Huo, Kristin R Landis-Piwowar, et al.
Acta Crystallographica. Section C, Structural Chemistry|December 4, 2020
Dibenzoate esters of cis-tetralin-2,3-diol as analogs of (-)-epigallocatechin gallate: synthesis and crystal structure of anticancer drug candidatesRyan Noboru Rutherford, Shinji Ura, Tak Hang Chan, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Recent advances on tea polyphenolsJyoti Kanwar, Mujtaba Taskeen, Imthiyaz Mohammad, et al.
Cancer Letters|October 13, 2017
A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancerJianzhang Wang, Gene Chi Wai Man, Tak Hang Chan, et al.
International Journal of Molecular Medicine|July 3, 2010
Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogsJyoti Kanwar, Imthiyaz Mohammad, Huanjie Yang, et al.
Anticancer Research|May 27, 2004
Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitorsAslamuzzaman Kazi, Zhigang Wang, Naveen Kumar, et al.
Advances in Clinical Chemistry|March 17, 2011
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatmentDi Chen, Sheng Biao Wan, Huanjie Yang, et al.
Molecular Medicine (Cambridge, Mass.)|October 24, 2002
Synthetic analogs of green tea polyphenols as proteasome inhibitorsDavid M Smith, Zhigang Wang, Aslamuzzaman Kazi, et al.
Nutrients|May 23, 2017
(-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In VitroKa-Chun Wong, Sisi Cao, Xiaoli Dong, et al.
The Journal of Antimicrobial Chemotherapy|April 21, 2009
Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite LeishmaniaIris L K Wong, Kin-Fai Chan, Yunzhe Zhao, et al.
Pageof 10